Anti-CGRP biologics: A new era for migraine prevention

CGRP is at the centre of migraines. Its potential to influence the pain pathway and its use as a biomarker makes it a topic of strong interest when discussing treatment options. Prof. Anthony Dickenson explains how studying CGRP and understanding how it sensitises pain signals in the nervous system can help develop therapies that can eventually ‘reset’ the nervous system and even create long-te